pyrrolidonecarboxylic acid has been researched along with Pain in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akar, F; Bektas, E; Celikyurt, IK; Erden, F; Kaya, H; Mutlu, O; Tanyeri, P; Ulak, G | 1 |
| Katsuyama, S; Kohno, K; Komatsu, T; Sakurada, C; Sakurada, S; Sakurada, T; Shiohira, H; Tsuzuki, M | 1 |
| Mizoguchi, H; Sakurada, S; Watanabe, C; Yonezawa, A | 1 |
| Kunadi, AR; Reddi, AS | 1 |
| Kato, M; Kuramasu, A; Mobarakeh, JI; Orito, T; Sakurada, S; Sakurai, E; Yanai, K; Yoshida, A | 1 |
| Katsumata, K; Kisara, K; Ohba, M; Sakurada, S; Sakurada, T; Tan-No, K; Yogo, H | 1 |
| Baamonde, A; Hidalgo, A; Menéndez, L | 1 |
| Alvarez-Vega, M; Baamonde, A; Gutiérrez, M; Hidalgo, A; Menéndez, L | 1 |
| Bachir, D; Beuzard, Y; Brugnara, C; Cynober, T; De Franceschi, L; Galacteros, F; Neuberg, D; Tchernia, G | 1 |
| Alvarez-Vega, M; Baamonde, A; Hidalgo, A; Menéndez, L | 1 |
| Barletta, FP; Baroncini, L; Benassi, L; Bertani, D; Beski, L; Filippini, F; Nani, A; Tesauri, P; Tridenti, G | 1 |
1 review(s) available for pyrrolidonecarboxylic acid and Pain
| Article | Year |
|---|---|
Recurrent anion gap metabolic acidosis in a woman with vertebral disc disease.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Analgesics, Non-Narcotic; Emergency Service, Hospital; Female; Humans; Middle Aged; Pain; Pyrrolidonecarboxylic Acid; Recurrence; Spinal Diseases | 2011 |
10 other study(ies) available for pyrrolidonecarboxylic acid and Pain
| Article | Year |
|---|---|
Effects of Acute Administration of Adipokinetic Hormone on Depression, Anxiety, Pain, Locomotion and Memory in Mice.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Insect Hormones; Locomotion; Locusta migratoria; Male; Memory; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Oligopeptides; Pain; Pyrrolidonecarboxylic Acid; Treatment Outcome | 2017 |
Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
Topics: Analgesics; Animals; Behavior, Animal; Butadienes; Central Nervous System Stimulants; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Injections, Spinal; Isoindoles; Male; Mice; Mice, Inbred Strains; Morphine Derivatives; Nitric Oxide; Nitriles; Nociceptors; Pain; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Receptors, Tachykinin; Specific Pathogen-Free Organisms; Spinal Cord; Stereoisomerism; Substance P | 2009 |
Characterization of intrathecally administered hemokinin-1-induced nociceptive behaviors in mice.
Topics: Analgesics; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Spinal; Lumbar Vertebrae; Male; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Pain; Pain Measurement; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Receptors, Neurokinin-1; Spinal Nerves; Substance P; Synaptic Transmission; Tachykinins; Time Factors | 2010 |
Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice.
Topics: 2-Amino-5-phosphonovalerate; Analgesics; Animals; Behavior, Animal; Capsaicin; Excitatory Amino Acid Antagonists; Female; Formaldehyde; Histamine; Histidine Decarboxylase; Injections, Spinal; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Pain; Pain Measurement; Peptide Fragments; Pyrrolidonecarboxylic Acid; Receptors, Histamine H1; Receptors, Neurokinin-1; Substance P; Time Factors | 2005 |
The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test.
Topics: Animals; Behavior, Animal; Formaldehyde; Injections, Spinal; Male; Mice; Mice, Inbred Strains; Neurokinin-1 Receptor Antagonists; Pain; Pain Measurement; Peptide Fragments; Pyrrolidonecarboxylic Acid; Substance P | 1995 |
Spinal calmodulin inhibitors reduce N-methyl-D-aspartate- and septide-induced nociceptive behavior.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Enzyme Inhibitors; Imidazoles; Injections, Intraventricular; Male; N-Methylaspartate; Neurokinin A; Pain; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Spinal Cord; Substance P; Sulfonamides | 1997 |
Comparison of the effects of calmidazolium, morphine and bupivacaine on N-methyl-D-aspartate- and septide-induced nociceptive behaviour.
Topics: Analgesics; Animals; Bupivacaine; Imidazoles; Male; Morphine; N-Methylaspartate; Pain; Pain Measurement; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Spinal Cord; Substance P | 1998 |
Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
Topics: Administration, Oral; Adult; Aged; Anemia, Sickle Cell; Erythrocytes; Humans; Middle Aged; Pain; Potassium; Pyrrolidonecarboxylic Acid; Sodium | 2000 |
Effects of the calcium release inhibitor dantrolene and the Ca2+-ATPase inhibitor thapsigargin on spinal nociception in rats.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics; Animals; Behavior, Animal; Calcium; Calcium-Transporting ATPases; Dantrolene; Enzyme Inhibitors; Male; Muscle Relaxants, Central; N-Methylaspartate; Pain; Pain Measurement; Peptide Fragments; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Spinal Cord; Substance P; Thapsigargin | 2001 |
Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea.
Topics: Adult; Dysmenorrhea; Female; Humans; Magnesium Deficiency; Menstruation; Pain; Pyrrolidonecarboxylic Acid | 1992 |